Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Total Liabilities 2012–2025
Catalyst Pharmaceuticals Inc. annual total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Catalyst Pharmaceuticals Inc. total liabilities as of December 31, 2025: 149.7M, a 20.95% increase year-over-year.
- Catalyst Pharmaceuticals Inc. total liabilities for 2025 were 149.7M, a 20.95% increase from 2024.
- Catalyst Pharmaceuticals Inc. total liabilities for 2024 were 123.8M, a 50.52% increase from 2023.
- Catalyst Pharmaceuticals Inc. total liabilities for 2023 were 82.2M, a 9.34% increase from 2022.
- Catalyst Pharmaceuticals Inc. total liabilities for 2022 were 75.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Catalyst Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $150 |
| 2024 | $124 |
| 2023 | $82 |
| 2022 | $75 |
| 2021 | $31 |
| 2020 | $23 |
| 2019 | $25 |
| 2018 | $10 |
| 2017 | $4 |
| 2016 | $2 |
| 2015 | $5 |
| 2014 | $9 |
| 2013 | $4 |
| 2012 | $2 |
Catalyst Pharmaceuticals Inc. Total Liabilities — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPRX's total liabilities history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.